Journal Club: All Recent News

Basaglar challenges Sanofi's insulin drug Lantus

(Apr 14 2017)

Submission of Application for Marketing Approval of CT-P6 Trastuzumab Biosimilar Monoclonal Antibody in Japan

(Apr 11 2017)

China FDA Accepts JHL’s First Clinical Trial Application

(Apr 5 2017)

Biosimilar BRENZYS (etanercept) available on PBS from 1st April

(Mar 30 2017)

BIOCAD keeps on supplying its medicine for blood cancer treatment in Vietnam

(Mar 30 2017)

JHL Doses First Patient In JHL1101 Phase I European Trial

(Mar 29 2017)

European Commission Approves AMGEVITA (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases

(Mar 23 2017)

Spotlight On: Medicines for Europe speaks out on past successes, current issues and future challenges in the European biosimilars market

(Mar 23 2017)

Biosimilar Medicines: A Game Changer for Oncology Care

(Mar 23 2017)

Roche reaches global settlement, licensing agreements with Mylan on Herceptin biosimilar

(Mar 13 2017)

EBE, EFPIA and IFPMA have today launched a position paper entitled “Considerations for physicians on switching decisions regarding biosimilars”

(Mar 9 2017)

New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine

(Mar 5 2017)

Delhi High Court Permits Biocon And Mylan To Sell Cancer Drugs As Biosimilars

(Mar 3 2017)

The UK High Court of Justice (Patents) Rules in Fujifilm Kyowa Kirin Biologics' Favor on Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis Dosing Regimens for Adalimumab Are Obvious and Unpatentable

(Mar 3 2017)

BIOCAD: The first ever biosimilar of interferon beta-1a approved in Russia

(Mar 3 2017)

Statement by Coherus CEO Regarding Biosimilars User Fees

(Mar 2 2017)

Coherus Announces CHS-1420 Pharmacokinetic Clinical Bioequivalence Study Meets Primary Endpoint

(Mar 2 2017)

Biocon, Mylan breast cancer drugs approved by DCGI: HC told

(Mar 2 2017)

Xbrane Biopharma releases 2016 Year End Report

(Feb 26 2017)

Xbrane Biopharma reports positive in-vitro biosimilarity data on Xlucane

(Feb 26 2017)

Pages